Menstrual exacerbation of schizophrenia symptoms

Acta Psychiatrica Scandinavica

Volumn 125, Issue 5, 2012, Pages 363-371

  Seeman, M V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Menstrual psychosis; Premenstrual dysphoric disorder; Schizophrenia; Symptom exacerbation

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; GONADORELIN AGONIST; HALOPERIDOL; PROGESTERONE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ARTICLE; ATTENUATION; BRAIN FUNCTION; DEPRESSION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; EXERCISE; HORMONAL THERAPY; HUMAN; MANIA; MEDICAL DECISION MAKING; MEDLINE; MENARCHE; MENSTRUAL CYCLE; MENSTRUATION; MORPHOLOGY; OVULATION INHIBITION; PREMENSTRUAL DYSPHORIC DISORDER; PREVALENCE; PRIORITY JOURNAL; PUERPERAL PSYCHOSIS; PUERPERIUM; SCHIZOPHRENIA; SUPPLEMENTATION; SYMPTOM; SYSTEMATIC REVIEW; TRANSDERMAL PATCH; TREATMENT DURATION; WOMEN'S HEALTH;

ANTIPSYCHOTIC AGENTS; DRUG INTERACTIONS; ESTROGENS; FEMALE; HUMANS; MENSTRUAL CYCLE; PREMENSTRUAL SYNDROME; PROGESTERONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 84859829683     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01822.x     Document Type: Article

References (85)

1. ####645349 Menstrual cycle vs. stability in schizophrenia? vBulletin®, Copyright ©2000-2011, Jelsoft Enterprises Ltd. Accessed Sept. 25, 2011.
2. Anonymous. Does pms normally cause psychosis to become worse? 09/12/10 Accessed Sept. 25, 2011.
3. Huber TJ, Borsutzky M, Schneider U, Emrich HM. Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis. Acta Psychiatr Scand 2004;109:269-274.
4. Seeman MV, Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull 1990;16:185-194.
5. Huber TJ, Tettenborn C, Leifke E, Emrich HM. Sex hormones in psychotic men. Psychoneuroendocrinology 2005;30:111-114.
6. Singh M. Progestins and neuroprotection: are all progestins created equal? Minerva Endocrinol 2007;32:95-102.
7. Singh M, Sumien N, Kyser C, Simpkins JW. Estrogens and progesterones as neuroprotectants: what animal models teach us. Front Biosci 2008;13:1083-1089.
8. Wieck A, Davies RA, Hirst AD et al. Menstrual cycle effects on hypothalamic dopamine receptor function in women with a history of puerperal bipolar disorder. J Psychopharmacol 2003;17:204-209.
9. Czoty PW, Riddick NV, Gage HD et al. Effect of menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus monkeys. Neuropsychopharmacology 2009;34:548-554.
10. Kendler KS, Schaffner KF. The dopamine hypothesis of schizophrenia: an historical and philosophical analysis. Philos Psychiatry Psychol 2011;18:41-63.
11. Goldstein JM, Jerram M, Poldrack R et al. Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci 2005;25:9309-9316.
12. Goldstein JM, Jerram M, Abbs B, Whitfield-Gabrieli S, Makris N. Sex differences in stress response circuitry activation dependent on female hormonal cycle. J Neurosci 2010;30:431-438.
13. Read J, Van OSJ, Morrison AP, Ross CA. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand 2005;112:330-350.
14. Wilson ME, Westberry JM, Trout AL. Estrogen receptor-alpha gene expression in the cortex: sex differences during development and in adulthood. Horm Behav 2011;59:353-357.
15. Molloy C, Conroy RM, Cotter DR, Cannon M. Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies. Schizophr Bull 2011;37:1104-1110.
16. Choi SH, Kang SB, Joe SH. Changes in premenstrual symptoms in women with schizophrenia: a prospective study. Psychosom Med 2001;63:822-829.
17. Hallonquist JD, Seeman MV, Lang M, Rector NA. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 1993;33:207-209.
18. Riecher-Rössler A, Häfner H, Stumbaum M, Maurer K, Schmidt R. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994;20:203-214.
19. Harris AH. Menstrually related symptom changes in women with schizophrenia. Schizophr Res 1997;27:93-99.
20. Halari R, Kumari V, Mehrotra R, Wheeler M, Hines M, Sharma T. The relationship of sex hormones and cortisol with cognitive functioning in schizophrenia. J Psychopharmacol 2004;18:366-374.
21. Thompson K, Sergejew A, Kulkarni J. Estrogen affects cognition in women with psychosis. Psychiatry Res 2000;94:201-209.
22. Althaus G, Pfuhlmann B, Franzek E. The effect of the menstruation cycle on manifestations of pychiatric diseases. Fortschr Neurol Psychiatr 2000;68:357-362.
23. Targum SD, Caputo KP, Ball SK. Menstrual cycle phase and psychiatric admissions. J Affect Disord 1991;22:49-53.
24. Gattaz WF, Vogel P, Riecher-Rössler A, Soddu G. Influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biol Psychiatry 1994;36:137-139.
25. Vanurová I, Yamamotová A. Phases of the menstrual cycle and therapeutic response to neuroleptic therapy in patients with schizophrenia. Cas Lek Cesk 2001;140:668-670.
26. Bergemann N, Parzer P, Nagl I et al. Acute psychiatric admission and menstrual cycle phase in women with schizophrenia. Arch Womens Ment Health 2002;5:119-126.
27. Lande RG, Karamchandani V. Chronic mental illness and the menstrual cycle. J Am Osteopath Assoc 2002;102:655-659.
28. Brockington I. Menstrual psychosis. World Psychiatry 2005;4:9-17.
29. Mahe V, Dumaine A. Oestrogen withdrawal associated psychoses. Acta Psychiatr Scand 2001;104:323-331.
30. Baptista T, Beaulieu S. The hypothesis of oestrogen withdrawal associated psychoses and the paradox of antipsychotic drug-induced hypoestrogenaemia. Acta Psychiatr Scand 2002;105:473-474.
31. Lindamer LA, Lohr JB, Harris MJ, Jeste DV. Gender, estrogen, and schizophrenia. Focus 2004;2:138-145.
32. Bergemann N, Parzer P, Runnebaum B, Resch F, Mundt C. Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia. Psychol Med 2007;37:1427-1436.
33. Rubin LH, Carter CS, Drogos L, Pournajafi-Nazarloo H, Sweeney JA, Maki PM. Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophr Res 2010;124:13-21.
34. Caldwell HK, Stephens SL, Young WS III. Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice. Mol Psychiatry 2009;14:190-196.
35. Dias RS, Lafer B, Russo C et al. Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: findings from STEP-BD. Am J Psychiatry 2011;168:386-394.
36. Edler C, Lipson SF, Keel PK. Ovarian hormones and binge eating in bulimia nervosa. Psychol Med 2007;37:131-141.
37. Forray A, Focseneanu M, Pittman B, Mcdougle CJ, Epperson CN. Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period. J Clin Psychiatry 2010;71:1061-1068.
38. Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci 2008;33:291-301.
39. Sit D, Seltman H, Wisner KL. Menstrual effects on mood symptoms in treated women with bipolar disorder. Bipolar Disord 2011;13:310-317.
40. Rhudy JL, Bartley EJ. The effect of the menstrual cycle on affective modulation of pain and nociception in healthy women. Pain 2010;149:365-372.
41. Macgregor EA. Perimenstrual headaches: unmet needs. Curr Pain Headache Rep 2008;12:468-474.
42. Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA 2006;295:1824-1830.
43. Pinkerton JV, Guico-Pabia CJ, Taylor HS. Menstrual cycle-related exacerbation of disease. Am J Obstet Gynecol 2010;202:221-231.
44. Kiessner J. One woman's low is another woman's high: paradoxical effects of the menstrual cycle. Psychoneuroendocrinology 2011;36:68-76.
45. Hagemann G, Ugur T, Schleussner E et al. Changes in brain size during the menstrual cycle. PLoS ONE 2011;6:e14655.
46. Watson CS, Alyea RA, Cunningham KA, Jeng Y-J. Estrogens of multiple classes and their role in mental health disease mechanisms. Int J Womens Health 2010;2:153-166.
47. Markham JA. Sex steroids and schizophrenia. Rev Endocr Metab Disord 2011; May 21. [Epub ahead of print] doi:.
48. Ko YH, Joe SH, Cho W et al. Estrogen, cognitive function and negative symptoms in female schizophrenia. Neuropsychobiology 2006;53:169-175.
49. Vahia IV, Palmer BW, Depp C et al. Is late-onset schizophrenia a subtype of schizophrenia? Acta Psychiatr Scand 2010;122:414-426.
50. Mendrek A, Stip E. Sexual dimorphism in schizophrenia: is there a need for gender-based protocols? Expert Rev Neurother 2011;11:951-959.
51. Cohen RZ, Seeman MV, Gotowiec A, Kopala L. Earlier puberty as a predictor of later onset of schizophrenia in women. Am J Psychiatry 1999;156:1059-1064.
52. Welham J, Scott J, Williams G, Najman J, O'callaghan M, Mcgrath J. Growth in young adults who screen positive for non-affective psychosis: birth cohort study. Austr NZ J Psychiatry 2009;43:61-67.
53. Boden JM, Fergusson DM, Horwood LJ. Age of menarche and psychosocial outcomes in a New Zealand birth cohort. J Am Acad Child Adolesc Psychiatry 2011;50:132-140.e5.
54. Kulkarni J. Oestrogen - a new treatment approach for schizophrenia? Med J Aust 2009;190(4 Suppl):S37-S38.
55. Riecher-Rössler A, Kulkarni J. Estrogens and gonadal function in schizophrenia and related psychoses. Curr Top Behav Neurosci 2011;8:155-171.
56. Akhondzadeh S, Nejatisafa AA, Amini H et al. Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:1007-1012.
57. Louzã MR, Marques AP, Elkis H, Bassitt D, Diegoli M, Gattaz WF. Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study. Schizophr Res 2004;66:97-100.
58. Bergemann N, Mundt C, Parzer P et al. Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double-blind study. Schizophr Res 2005;74:125-134.
59. Chua WLLC, Izquierdo De Saniago A, Kulkarni J, Mortimer A. Estrogen for schizophrenia. Cochrane Database Syst Rev 2005;Oct 19(4):CD004719.
60. Kulkarni J, De Castella A, Fitzgerald PB et al. Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 2008;65:955-960.
61. Wroolie TE, Kenna HA, Williams KE et al. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens. Am J Geriatric Psychiatry 2011;19:792-802.
62. Soldin OP, Chung SH, Mattison DR. Sex differences in drug disposition. J Biomed Biotechnol 2011. doi:.
63. Usall J, Suarez D, Haro JM, The SOHO Study Group. Gender differences in response to antipsychotic treatment in outpatients with schizophrenia. Psychiatry Res 2007;153:225-231.
64. Ballagh SA, Heyl A. Communicating with women about menstrual cycle symptoms. J Reprod Med 2008;53:837-846.
65. Goldberg J, Wolf A, Silberstein S et al. Evaluation of an electronic diary as a diagnostic tool to study headache and premenstrual symptoms in migraineurs. Headache 2007;47:384-396.
66. Feuerstein M, Shaw WS. Measurement properties of the calendar of premenstrual experience in patients with premenstrual syndrome. J Reprod Med 2002;47:279-289.
67. Coromina Sadurni M, Rodie JU, De Montagut LM, Sanchez AM. The use of oral contraceptives as a prevention of recurrent premenstrual psychosis. Psychiatry Res 2009;170:290-291.
68. Liao D-L, Chen H, Shin-Lee S-M, Tsai S-J. Estrogen supplementation for female schizophrenics treated with atypical antipsychotics. Gen Hosp Psychiatry 2002;24:357-359.
69. Chetty M, Miller R. Oral contraceptives increase the plasma concentrations of chlorpromazine. Ther Drug Monit 2001;23:556-558.
70. Gabbay V, O'dowd MA, Mamamtavrishvili M, Asnis GM. Clozapine and oral contraceptives: a possible drug interaction. J Clin Psychopharmacol 2002;22:621-622.
71. Cyr M, Calon F, Morissette M, Di Paolo T. Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. J Psychiatry Neurosci 2002;27:12-27.
72. Wong J, Seeman MV, Shapiro H. Raloxifene in postmenopausal women with psychosis: preliminary findings. Am J Geriatr Psychiatry 2003;11:697-698.
73. Kulkarni J, Gurvich C, Gilbert H et al. Hormone modulation: a novel therapeutic approach for women with severe mental illness. Austr NZ J Psychiatry 2008;42:83-88.
74. Kulkarni J. Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psychoneuroendocrinology 2010;35:1142-1147.
75. Usall J, Huerta-Ramos E, Iniesta R et al. Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 2011;72:1552-1557.
76. Mwinyi J, Cavaco I, Pedersen RS et al. Regulation of CYP2C19 expression by estrogen receptor α: implications for estrogen-dependent inhibition of drug metabolism. Mol Pharmacol 2010;78:886-894.
77. Mwinyi J, Cavaco I, Yurdakok B, Mkrtchian S, Ingelman-Sundberg M. The ligands of the estrogen receptor α regulate cytochrome P4502C9 (CYP2C9) expression. J Pharmacol Exp Ther 2011;338:302-309.
78. Freeman EW. Therapeutic management of premenstrual syndrome. Expert Opin Pharmacother 2010;11:2879-2889.
79. Hsiao M-C, Liu CY. Unusual manifestations of premenstrual syndrome. Psychiatry Clin Neurosci 2007;61:120-123.
80. 2 receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia. J Clin Psychiatry 2010;71:1131-1137.
81. Kasckow J, Lanouette N, Patterson T et al. Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning. Int J Geriatr Psychiatry 2010;25:183-190.
82. Buchanan RW, Kreyenbuhl J, Kelly DL et al. The 2009 Schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 2010;36:71-93.
83. Hsiao MC, Hsiao CC, Liu CY. Premenstrual symptoms and premenstrual exacerbation in patients with psychiatric disorders. Psychiatry Clin Neurosci 2004;58:186-190.
84. Shivakumar G, Bernstein IH, Suppes T et al. Are bipolar mood symptoms affected by the phase of the menstrual cycle? J Womens Health (Larchmt) 2008;17:473-478.
85. Deuchar N, Brockington I. Puerperal and menstrual psychoses: the proposal of a unitary etiological hypothesis. J Psychosom Obstet Gynaecol 1998;19:104-110.